Market research
QPT.V Quest PharmaTech Inc
V CAD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 3M
- P/E ratio
- 0.67
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- -0.31
Community
Investor discussion
1 comment
Sign in to join the QPT.V discussion.
5 years, 5 months ago
Quest PharmaTech Inc is currently in a long term downtrend where the price is trading 34.3% below its 200 day moving average.
From a valuation standpoint, the stock is 49.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 516.0.
Quest PharmaTech Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 336.0% to $4M since the same quarter in the previous year.
Finally, its free cash flow grew by 93.8% to $-103K since the same quarter in the previous year.
Based on the above factors, Quest PharmaTech Inc gets an overall score of 3/5.